Delivery Order SPE2DB20D1100-SPE2DB25FA6F7
Award Date
2/13/25
Potential Completion Date
2/14/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,899.57, is for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML, a medical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award is an order under a delivery order contract issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,924.35 contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product, to support military healthcare programs. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $4,579.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product, with a period of performance through January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,264.66, is for the supply of BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $5,203.54 and covers the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML medical products. The contract is a Firm Fixed Price Delivery Order with a completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BARHEMSYS 10 MG/4 ML VIAL 4ML. The $1,389.46 firm fixed-price delivery order falls under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award, valued at $5,937.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a medical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $1,462.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product, with a completion date of December 13, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is a delivery order valued at $2,389.47 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract covers the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product, to support military healthcare programs globally. The IDC provides a comprehensive vehicle for AmerisourceBergen to deliver a range of pharmaceutical products and...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order (SPE2DB22D1106|SPE2DB25FDQR0) valued at $5,227.55 for BARHEMSYS 10 MG/4 ML VIAL 4ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor for this award, which is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...